Vyne Therapeutics earnings were -$21.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest VYNE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.6M, down 25.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VYNE reported annual earnings of -$26.5M, with -33.5% growth. The next VYNE earnings date is Aug 13, 2026.
What were Vyne Therapeutics's earnings last quarter?
Vyne Therapeutics (NASDAQ: VYNE) reported Q1 2026 earnings per share (EPS) of -$0.08, up 60% year over year. Total VYNE earnings for the quarter were -$3.59 million. In the same quarter last year, Vyne Therapeutics's earnings per share (EPS) was -$0.20.
The next VYNE earnings date is Invalid Date. Add VYNE to your watchlist to be reminded of Vyne Therapeutics's next earnings date.
What was VYNE's earnings growth in the past year?
As of Vyne Therapeutics's earnings date in Q3 2026, Vyne Therapeutics's earnings has grown year over year. VYNE earnings in the past year totalled -$21.46 million.
Is Vyne Therapeutics profitable or losing money?
As of the last Vyne Therapeutics earnings report, Vyne Therapeutics is currently losing money. Vyne Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$21.46 million, a 49.15% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.